The epidemiology and management of severe hypertension

Journal of Human Hypertension

Volumn 24, Issue 1, 2010, Pages 9-18

  Borzecki, A M ^a,b,c   Kader, B ^a,b,c   Berlowitz, D R ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic hypertension; Epidemiology; Therapy

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY;

AGED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77449155234     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.37     Document Type: Article

References (27)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-19.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
5. Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
6. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
8. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
10. Salerno CM, Demopoulos L, Mukherjee R, Gradman AH. Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension. J Clin Hypertens (Greenwich) 2004; 6: 614-620.
11. Flack JM, Hamaty M. Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes. J Hypertens Suppl 1999; 17: S19-S24.
12. Lalljie GR, Lalljie SE. Characteristics and control of severe hypertension in a specialist, private practice in Jamaica. West Indian Med J 2005; 54: 315-318.
13. Marquez-Contreras E, Coca A, von de la Figuera Wichmann M, Divison JA, Llisterri JL, Sobrino J et al. Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study. Med Clin (Bare) 2007; 128: 86-91.
14. Preston RA, Baltodano NM, Cienki J, Materson BJ. Clinical presentation and management of patients with uncontrolled, severe hypertension: results from a public teaching hospital. J Hum Hypertens 1999; 13: 249-255.
15. Borzecki AM, Glickman ME, Kader B, Berlowitz DR. The effect of age on hypertension control and management. Am J Hypertens 2006; 19: 520-527.
16. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Can we use automated data to assess quality of hypertension care? Am J Manag Care 2004; 10: 473-479.
17. VA Information Resource Center: Toolkit for new users of VA data Available at. http://www.virec.research.va. gov/Support/Training-NewUsersToolkit/Toolkit.htm. Accessed March 2008.
18. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? Am J Med Qual 2004; 19: 201-206.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6): 613-619.
20. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339(27): 1957-1963.
21. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Hypertension control: how well are we doing? Arch Intern Med 2003; 163: 2705-2711.
22. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the US. N Engl J Med 2001; 345: 479-486.
23. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the US, 1988-2000. JAMA 2003; 290: 199-206.
24. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4: 393-405.
25. Berlowitz DR, Cushman WC, Glassman P. Hypertension in adults across age groups. JAMA 2005; 294: 2970-2971;author reply 2971-2972.
26. Yu W, Ravelo A, Wagner TH et al. Prevalence and costs of chronic conditions in the VA Health Care System. Med Care Res Rev 2003; 60(3 Suppl): 146S-167S.
27. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subrama-nian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 2008; 148: 717-727.